BRAND_ANALYSIS #ILLUMINA HEALTH & PHARMA #14 OF 26 IN HEALTH & PHARMA ALIGNED

Illumina

· Public · Updated 23 Aug 2026 07:27 UTC
#534 of 1208 overall by tension · #14 of 26 in Health & Pharma
13 Aligned
The Balanced
Analysis

A genomics play with actual market momentum (+11.45% in 30 days) yet C=50, B=63 with 0.50 sentiment—pure institutional B2B with no consumer narrative. The stock moved; the brand didn't.

IN THE NEWS (55 articles this week)
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
Illumina, Inc. Post Earnings: Buy On A Pullback (NASDAQ:ILMN) - Seeking Alpha
Did Illumina’s (ILMN) New Debt Deal and Credit Line Refresh Just Shift Its Investment Narrative? - simplywall.st
Cultural Score
50 / 100
Business Score
63 / 100
TREND
TENSION▁▂▁▁▁▁▁▂▁▁▁▁▂▁
CULTURAL▄▄▄▄▄▄▄▃▄▄▄▄▄▄
BUSINESS▄▆▅▅▄▄▄▄▄▄▄▄▅▅
TREND CHART
Loading...
CULTURAL BREAKDOWN
Wikipedia Momentum 15/40
News Presence 36/35
Search InterestRedistributed to other dimensions
BUSINESS BREAKDOWN
Stock Momentum 27/30
Market Position 16/25
Revenue Growth 3/25
Earnings Health 17/20
STOCK DATA
Price$219.40
30d Change+11.4%
Market Cap$33.1B
Profit Margin18.3%
BRANDS LIKE THIS
Calm
C:50 B:62 T:12
Siemens Healthineers
C:53 B:66 T:13
Epic Systems
C:46 B:60 T:14
Neko Health
C:47 B:59 T:12
UnitedHealthcare
C:45 B:60 T:15
SHARE
Illumina's tension is 13. Commerce outpacing culture. sociologyofcapitalism.com/brand/illumina
SHARE ON X
EMBED
<iframe src="https://sociologyofcapitalism.com/embed/illumina.html" width="320" height="200" frameborder="0"></iframe>
Data: Wikipedia Pageviews, Google News RSS, AI Sentiment, Yahoo Finance
All scores approximate. Updated daily.
Sociology of Capitalism
Mike Litman